Table 2.
Follow-up outcomes of sacral colpopexy patients according to 3-months IPAQ-SF levels
| LOW IPAQ-SF 127 pts | M-H IPAQ-SF 98 pts | P | ||
|---|---|---|---|---|
| 3 months FU | Anatomic failure, n (%) | 3/127 (2) | 1/98 (1) | > 0.05 |
| Anterior, n (%) | 1/127 (1) | 0/98 (0) | > 0.05 | |
| Apical, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 | |
| Posterior, n (%) | 2/127 (1) | 1/98 (1) | > 0.05 | |
| Mesh erosion, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 | |
| PGI-I successful outcomes, n (%) | 109/127 (86) | 87/98 (88) | > 0.05 | |
| POPDI-6, median (range) | 7 (6–11) | 8 (6–12) | > 0.05 * | |
| PISQ-12, median (range) | 71 (65–91) | 74 (69–94) | > 0.05 * | |
| De novo Defecatory dysfunctions, n (%) | 0/127 (0) | 2/98 (2) | > 0.05 | |
| 6 months FU | Anatomic failure, n (%) | 3/127 (2) | 1/98 (1) | > 0.05 |
| Anterior, n (%) | 1/127 (1) | 0/98 (0) | > 0.05 | |
| Apical, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 | |
| Posterior, n (%) | 2/127 (1) | 1/98 (1) | > 0.05 | |
| Mesh erosion, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 | |
| PGI-I successful outcomes, n (%) | 106/127 (83) | 83/98 (84) | > 0.05 | |
| POPDI-6, median (range) | 10 (8–14) | 11 (8–15) | > 0.05 * | |
| PISQ-12, median (range) | 68 (62–88) | 70 (65–91) | > 0.05 * | |
| De novo Defecatory dysfunctions, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 | |
| 2 years FU | Anatomic failure, n (%) | 4/127 (3) | 2/98 (2) | > 0.05 |
| Anterior, n (%) | 1/127 (1) | 0/98 (0) | > 0.05 | |
| Apical, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 | |
| Posterior, n (%) | 3/127 (2) | 2/98 (2) | > 0.05 | |
| Mesh erosion, n (%) | 1/127 (1) | 0/98 (0) | > 0.05 | |
| PGI-I successful outcomes, n (%) | 101/127 (80) | 80/98 (81) | > 0.05 | |
| POPDI-6, median (range) | 11 (8–15) | 13 (9–17) | > 0.05 * | |
| PISQ-12, median (range) | 66 (61–87) | 66 (62–88) | > 0.05 * | |
| De novo Defecatory dysfunctions, n (%) | 0/127 (0) | 0/98 (0) | > 0.05 |
Range, percentile range (25th–75th); *: p < 0.05 from baseline; Anatomic failure: POP-Q stage ≥ II at any site; POPDI-6: “Pelvic Organ Prolapse Distress Inventory—6”; PISQ-12: “Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire—12”
Two-sided significance level set at p < 0.05